Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2025 Earnings Call Transcript October 30, 2025
Apellis Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.67, expectations were $1.03.
Operator: Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the Apellis Pharmaceuticals Third Quarter 2025 Earnings Conference Call. Please be advised that today’s conference is being recorded. I would now like to turn the call over to Eva Stroynowski, Head of...
